MiR-1231 decrease the risk of cancer-related mortality in patients combined with non-small cell lung cancer and diabetes mellitus | Cancer Cell International | Full Text

MiR-1231 decrease the risk of cancer-related mortality in patients combined with non-small cell lung cancer and diabetes mellitus | Cancer Cell International | Full Text

MiR-1231 decrease the risk of cancer-related mortality in patients combined with non-small cell lung cancer and diabetes mellitus

Non-small cell lung cancer (NSCLC) is a deadly human malignancy, and previous studies support the contribution of microRNAs (miRNAs) to cancer assessment. It has been reported that miR-1231 can be used as a bi...

Authors:Jing Li, Jialiang Xu, Zhijun Cao, Shouzuo Du and Luyu Zhang

Citation:Cancer Cell International 2020 20:438

Content type:Primary research

 

Published on: 7 September 2020

• ViewFull Text
 
• ViewPDF